Abstract:Context: Pheochromocytomas and paragangliomas (PPGLs) are believed to harbor malignant potential; about 10% to 15% of pheochromocytomas and up to 50% of abdominal paragangliomas will exhibit metastatic behavior. Evidence acquisition: Extensive searches in the PubMed database with various combinations of the key words pheochromocytoma, paraganglioma, metastatic, malignant, diagnosis, pathology, genetic, and treatment were the basis for the present review. Data synthesis: To pinpoint metastatic potential in PPGLs is difficult, but nevertheless crucial for the individual patient to receive tailor-made follow-up and adjuvant treatment following primary surgery. A combination of histological workup and molecular predictive markers can possibly aid the clinicians in this aspect. Most patients with PPGLs have localized disease and may be cured by surgery. Plasma metanephrines are the main biochemical tests. Genetic testing is important, both for counseling and prognostic estimation. Apart from computed tomography and magnetic resonance imaging, molecular imaging using 68Ga-DOTATOC/DOTATATE should be performed. 123I-MIBG scintigraphy may be performed to determine whether 131I-MIBG therapy is a possible option. As first-line treatment in patients with metastatic disease, 177Lu-DOTATATE or 131I-MIBG is recommended, depending on which shows best expression. In patients with very low proliferative activity, watch-and-wait or primary treatment with long-acting somatostatin analogues may be considered. As second-line treatment, or first-line in patients with high proliferative rate, chemotherapy with temozolomide or cyclophosphamide + vincristine + dacarbazine is the therapy of choice. Other therapies, including sunitinib, cabozantinib, everolimus, and PD-1/PDL-1 inhibitors, have shown modest effect. Conclusions: Metastatic PPGLs need individualized management and should always be discussed in specialized and interdisciplinary tumor boards. Further studies and newer treatment modalities are urgently needed.

Treatment and Outcome of Metastatic Paraganglioma of the Spine

Surgical Management and Outcomes of Spinal Metastasis of Malignant Adrenal Tumor: A Retrospective Study of Six Cases and Literature Review

Clinical Features and Treatment of Spinal Metastatic Pheochromocytoma and Paraganglioma: a Single Institutional Experience with 18 Patients

Risk factors and prognosis of surgery for spinal metastasis

Treatment and Outcome of Malignant Giant Cell Tumor in the Spine

Surgical Treatment of Spinal Metastatic Pheochromocytoma and Paraganglioma: A Single Institutional Cohort of 18 Patients.

Diagnostic features and therapeutic strategies for malignant paraganglioma in a patient: A case report

Surgical management of extensive jugular paragangliomas: 10-year-experience with a large cohort of patients in China

The Diagnosis and Treatment of Intraspinal Paragangliomas

Treatment of metastatic paraganglioma: experience of a single center

Surgical Outcome and Prognosis of Patients with Spinal Metastasis from Esophageal Cancer: The Experience from a Single Center

Metastatic Pheochromocytomas and Abdominal Paragangliomas

Head and neck paragangliomas: Recent advances in translational and clinical research and guidelines for patient care

Malignant peripheral nerve sheath tumours of the spine: clinical manifestations, classification, treatment, and prognostic factors

The surgical treatment of metastatic spine tumors within the intramedullary compartment

Clinical characteristics of lumbar intraspinal paragangliomas

[Diagnosis and Treatment of Paragangliomas in the Central Nerve System].

Paraganglioma of the cauda equina: A case report and review of the literature

Analysis of clinical and pathological characteristics of retroperitoneal paraganglioma and associated prognostic factors

[New progress in the diagnosis and treatment of jugular paragangliomas]

Case Report: Paraganglioma in the sellar region: longitudinal observation and surgical outcome.